Watch this EuroPCR 2022 recording by Yoshinobu Onuma, Joanna Wykrzykowska, and Victor Alfonso Jimenez to understand why monotherapy following STEMI can be beneficial for patients, and why aspirin should be eliminated from post-PCI care, and to learn about the ASET SUPREME study.

View more videos and course...

Lars Søndergaard, Won-Keun Kim, and Christophe Saint Etienne came together for EuroPCR 2022 to share their experience of implanters achieving single-digit permanent pacemaker implantation: learn about the latest technique and new product features to reduce permanent pacemaker implantation.

View more videos and course resources here!

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.

Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.

Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.

This single-arm, double-blinded, core-laboratory adjudicated, prospective trial, conducted across four European centers between August 2019 and April 2022, investigates whether CCTA and FFR-CT are able to exclude hemodynamically significant coronary stenoses in patients with high-risk NSTE-ACS.

The EuroIntervention Journal is pleased to announce its 2021 Impact Factor: 7.728 (2021 Journal Citation Reports® Science Edition (Clarivate Analytics, 2022)

With this result, we confirm last year's progression and we are proud to be listed 2nd amongst interventional cardiology journals. 

Mirvat Alasnag interviews David Meier about his TCT2022 poster presentation which was simultaneously published in the EuroIntervention Journal: Timing of Bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity. EuroIntervention, Meier et al. DOI: 10.4244/EIJ-D-22-00644

Results show that bioprosthetic valve fracture performed after VIV appears to offer...

Watch Luis Ortega Paz's interview with David Berg as part of the ESC 2022 Congress coverage, and find out more about the COVID-PACT trial, which aims to study antithrombotic strategies in critically ill COVID-19 patients. Learn more about the study design (population, primary endpoint, safety criteria...)...

Aaysha Cader interviews Rania Hammami, Principal Investigator of the RIVARAD trial. They discuss the design and results of the trial which was presented during #TCT2022.

RIVARAD is the first multicentric randomized trial with 30-day RAOs as the primary endpoint, which proved the efficacy of short-term use of...

Watch this presentation by Thomas Modine for EuroPCR 2022 to hear about the multimodality approach to optimise TAVI procedure and its impact on post-operative course, to get an update on how minimalist TAVI can be performed successfully in most patients without conversion to general anaesthesia, and...

Watch this interview of Tom Johnson by Jan McCloud recorded for EuroPCR 2022 to understand how MLD MAX workflow improves decision-making, efficiency, and product utilisation, and how it can lower radiation exposure while keeping the contrast use constant when compared to angiography-guided PCI.

View more videos and course...

Join this discussion recorded in the PCR Live studio in London, where Sam Dawkins and Wolfgang Rottbauer, hosted by Jörg Hausleiter, talk about some new studies and clinical trials presented during PCR London Valves 2022. They also discuss the latest technologies available to treat mitral regurgitation.

View...

Thanks to this interview between Enrique Gutierrez Ibanez and Nicolas Meneveau shot for EuroPCR 2022, be aware of the clinical evidence and the studies currently ongoing for the “coronary artery disease and aortic stenosis” clinical setting, learn more about the current approach to diagnose and treat...

In this EuroPCR 2022 recording by Alison Duncan & Lenard Conradi, learn how to expand your mitral treatment options to include Tendyne TMVR therapy, understand the difference in patient management with the mitral standard of care, and optimise patient outcomes with Tendyne TMVR therapy through medical management best practices:...

Through this discussion between Yohei Ohno, Kendra Grubb, and Stefan James recorded for EuroPCR 2022, discover recent updates on the COT experience/studies (optimize PRO 400pts, OCEAN TAVI, personal experience), find out about key success factors/steps on the technique to achieve optimal results, and learn how to...

Follow this dialogue between Jochen Reinöhl and David Cohen, recorded for EuroPCR 2022, to find out more about clinical research: what exactly is the definition? What are the current challenges in conducting clinical research? How to ensure the participation of a diverse population? All the answers...

Elad Asher provides his take on this phase IIb trial in healthy people ages 50 to 80 showing that the novel intravenous treatment bentracimab significantly restored platelet function in patients receiving oral P2Y12 inhibitor ticagrelor. The clinical trial was presented by Deepak L. Bhatt at the American College of Cardiology...